What is the prevalence of Pseudohypoparathyroidism?

TL;DR: Pseudohypoparathyroidism is considered a rare endocrine disorder with an estimated global prevalence of approximately 1 in 20,000 to 1 in 100,000 people. Because the condition is frequently underdiagnosed or misdiagnosed due to its complex clinical presentation, these figures are considered estimates rather than exact counts.

What is the estimated prevalence and incidence of Pseudohypoparathyroidism?

Determining the exact prevalence of Pseudohypoparathyroidism is challenging because the condition encompasses a heterogeneous group of disorders. According to Orphanet and the NIH Genetic and Rare Diseases (GARD) Information Center, the prevalence is generally estimated to be between 1 in 20,000 and 1 in 100,000. Because Pseudohypoparathyroidism is a genetic condition, the incidence at birth is synonymous with its prevalence; however, because many individuals may remain asymptomatic or have mild features that do not prompt immediate clinical investigation, the true number of cases is likely higher than current diagnostic registries suggest.

How do age, gender, and geography impact Pseudohypoparathyroidism?

Pseudohypoparathyroidism typically presents in childhood or adolescence, though it is often diagnosed in adulthood when metabolic abnormalities or characteristic physical features—collectively known as Albright hereditary osteodystrophy—become more apparent. There is no significant evidence suggesting that the condition affects one gender more frequently than the other, though the inheritance pattern (often involving imprinting) can lead to different clinical manifestations depending on whether the genetic mutation is inherited from the mother or the father. Regarding geography and ethnicity, Pseudohypoparathyroidism does not show a clear bias toward any specific population, appearing globally across diverse ethnic groups.

Why is accurate data on Pseudohypoparathyroidism difficult to track?

The rarity of Pseudohypoparathyroidism contributes to a significant diagnostic delay. Several factors complicate epidemiological tracking:

• Clinical Heterogeneity: Patients may present with varying combinations of hormonal resistance and physical features, leading to misclassification.


• Underdiagnosis: Mild cases or those without significant hypocalcemia may not be identified until adulthood, if at all.


• Diagnostic Complexity: Specialized testing for GNAS gene mutations or hormonal resistance patterns is not always accessible in every clinical setting.


• Community Perspectives: Currently, 42 people with Pseudohypoparathyroidism have joined the DiseaseMaps.org community, providing a real-world perspective that complements clinical data by highlighting the lived experiences of patients navigating this diagnostic journey.

Is Pseudohypoparathyroidism considered a rare disease?

Yes, Pseudohypoparathyroidism is classified as a rare disease. In the medical community, it is defined by its low prevalence and the complexity of its underlying genetic mechanisms, specifically the resistance to parathyroid hormone (PTH). Because it requires multidisciplinary care from endocrinologists, geneticists, and pediatricians, patients often face hurdles in finding specialists who are familiar with the nuanced clinical management of Pseudohypoparathyroidism.

Next steps

• Consult with an endocrinologist experienced in rare metabolic bone disorders to review your specific clinical profile.


• Request a referral to a clinical geneticist for formal testing of the GNAS gene if Pseudohypoparathyroidism is suspected.


• Join the DiseaseMaps.org community to connect with other patients and caregivers sharing their experiences with Pseudohypoparathyroidism.


• Maintain a detailed medical history, including records of serum calcium, phosphate, and PTH levels, to assist your medical team in tracking the progression of the condition.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: "Pseudohypoparathyroidism" (ORPHA:748).


• NIH Genetic and Rare Diseases (GARD) Information Center: "Pseudohypoparathyroidism."


• OMIM (Online Mendelian Inheritance in Man): "Pseudohypoparathyroidism, Type Ia" (Entry #103580).


• The MAGIC Foundation: Resources for Endocrine Disorders and Rare Conditions.